Logo image
IRO Home Research units Researcher Profiles
Sign in
New and innovative interventions in the management of pemphigus
Journal article

New and innovative interventions in the management of pemphigus

A S Frydman and J A Fairley
Giornale italiano di dermatologia e venereologia, Vol.146(3), pp.211-224
06/2011
PMID: 21566551

View Online

Abstract

Pemphigus is a rare autoimmune blistering disease usually treated with systemic glucocorticoids with adjuvant immunosuppressants or anti-inflammatories. However significant morbidity and mortality is associated with these treatments. This review discusses conventional therapeutic options, as well as new and emerging therapies that may be safer alternatives to broad-based immunosuppression.
Glucocorticoids - therapeutic use Humans Immunosuppressive Agents - therapeutic use Risk Factors Dermatologic Agents - therapeutic use Pemphigus - drug therapy Plasmapheresis Randomized Controlled Trials as Topic Anti-Bacterial Agents - therapeutic use Immunosorbent Techniques Anti-Inflammatory Agents - therapeutic use Pemphigus - therapy Photopheresis Drug Therapy, Combination Immunologic Factors - therapeutic use

Details

Metrics

Logo image